Literature DB >> 20862830

Macrophage activation syndrome induced by etanercept in a patient with systemic sclerosis.

Gary Sterba1, Yonit Sterba, Carlos Stempel, Jack Blank, Evelyn Azor, Leslie Gomez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20862830

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


× No keyword cloud information.
  5 in total

Review 1.  Inflammatory arthritis in systemic sclerosis: What to do?

Authors:  Rebecca B Blank; Ogonna Kenechi Nwawka; Anna A Yusov; Jessica K Gordon
Journal:  J Scleroderma Relat Disord       Date:  2018-06-19

Review 2.  Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation.

Authors:  Isabelle Amigues; Alexander H Pearlman; Aarat Patel; Pankti Reid; Philip C Robinson; Rashmi Sinha; Alfred Hj Kim; Taryn Youngstein; Arundathi Jayatilleke; Maximilian Konig
Journal:  Expert Rev Clin Immunol       Date:  2020-11-25       Impact factor: 4.473

Review 3.  The Immunology of Macrophage Activation Syndrome.

Authors:  Courtney B Crayne; Sabrin Albeituni; Kim E Nichols; Randy Q Cron
Journal:  Front Immunol       Date:  2019-02-01       Impact factor: 7.561

Review 4.  Macrophage activation syndrome in a patient with axial spondyloarthritis on adalimumab.

Authors:  Rahaf Baker; Jean W Liew; Paul D Simonson; Lori A Soma; Gordon Starkebaum
Journal:  Clin Rheumatol       Date:  2018-12-07       Impact factor: 2.980

Review 5.  Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions.

Authors:  Yvan Jamilloux; Thomas Henry; Alexandre Belot; Sébastien Viel; Maxime Fauter; Thomas El Jammal; Thierry Walzer; Bruno François; Pascal Sève
Journal:  Autoimmun Rev       Date:  2020-05-04       Impact factor: 9.754
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.